Compare ICU & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICU | COSM |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 18.8M |
| IPO Year | N/A | 2013 |
| Metric | ICU | COSM |
|---|---|---|
| Price | $2.31 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 155.6K | ★ 937.7K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $881,000.00 | ★ $59,792,819.00 |
| Revenue This Year | $691.85 | $28.14 |
| Revenue Next Year | $64.17 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1195.59 | 6.69 |
| 52 Week Low | $2.20 | $0.28 |
| 52 Week High | $30.70 | $1.32 |
| Indicator | ICU | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 70.78 | 49.78 |
| Support Level | $2.49 | $0.42 |
| Resistance Level | $2.98 | $0.58 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 80.42 | 66.40 |
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.